A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma
Running, not enrolling · Phase 3
Conditions studied: Melanoma
In brief
The purpose of this study is to assess the efficacy, safety, and immunogenicity of ABP 206 compared with Nivolumab in Subjects with Treatment-Naïve Unresectable or Metastatic Melanoma.
Key facts
- Study ID
- NCT06054555
- Run by
- Amgen
- People needed
- 633
- Starts
- 2023-11-02
- Expected to finish
- 2028-01-25
- Last updated by the study team
- 2026-01-12
Who can join
Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Fort Wayne Medical Oncology and Hematology - Office of Clinical Research — Fort Wayne, Indiana, United States
- Our Lady of the Lake Physicians Group-Medical Oncology-Woman's Pavilion — Baton Rouge, Louisiana, United States
- Oncology Hematology Associates — Springfield, Missouri, United States
- Hematology-Oncology Associates of Central New York, P.C. (HOA) - East Syracuse - CCOP — East Syracuse, New York, United States
- Centro de Investigaciones Médicas y Desarrollo LC — Buenos Aires, Ciudad Autónoma de Buenos Aire, Argentina
- Centro De Investigaciones Medicas Mar Del Plata (CIMMDP) - Rheumatology — Mar Del Plata, Río Negro Province, Argentina
- Clínica Viedma - Oncology — Viedma, Río Negro Province, Argentina
- Instituto De Oncologia De Rosario — Rosario, Santa Fe Province, Argentina
- ISIS Clinica Especializada — Santa Fe, Argentina
- Clinical Center University of Sarajevo - Clinic of Oncology — Sarajevo, Kanton Sarajevo, Bosnia and Herzegovina
- University Clinical Center of Republic of Srpska — Banja Luka, Republika Srpska, Bosnia and Herzegovina
- University Clinical Center Tuzla - Oncology, Hematology and Radio — Tuzla, Tuzlanski Kanton, Bosnia and Herzegovina
- Cantonal hospital Zenica - Oncology — Zenica, Zeničko-dobojski Kanton, Bosnia and Herzegovina
- Dr. Everett Chalmers Hospital - Oncology — Fredericton, New Brunswick, Canada
- Centro de Investigacion y Desarrollo Oncologico — Temuco, Araucania, Chile
- IC La Serena Research — La Serena, Coquimbo Region, Chile
- Icegclinic Research & Care — Estacion Central, Santiago Metropolitan, Chile
- Oncocentro Apys — Valparaíso, Valparaiso, Chile
- University Hospital Centre Zagreb - Oncology department — Zagreb, City of Zagreb, Croatia
- Poliklinika Anova — Zagreb, City of Zagreb, Croatia
- Klinicki bolnicki centar Osijek — Osijek, Osjecko-baranjska Županija, Croatia
- FN Hradec Kralove - Klinika onkologie a radioterap — Hradec Kralove, Moravian-Silesian Region, Czechia
- Vseobecna fakultni nemocnice v Praze - Dermatovenerologicka — Prague, Czechia
- Tartu University Hospital - Oncology — Tartu, Tartu, Estonia
- Cancer and Blood Specialty clinic — Long Beach, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.